MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Carcinogenesis

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgs225PMID 22791819PMCID PMC3529557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cadherin switch from E‐ to N‐cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail

  2012cited by this paper
• The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma

  2011cited by this paper
• Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer

  2011cited by this paper
• Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin

  2011cited by this paper
• MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells

  2010cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• EMT: when epithelial cells decide to become mesenchymal-like cells.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic.

  2009cited by this paper
• MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

  2008cited by this paper
• Collagen I–mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1

  2008cited by this paper
• Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

  2008cited by this paper
• Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

  2008cited by this paper
• MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.

  2008cited by this paper
• MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.

  2008cited by this paper
• Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.

  2007cited by this paper
• A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

  2007cited by this paper
• Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.

  2007cited by this paper
• MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins

  2007cited by this paper
• Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer

  2007cited by this paper
• Metastasis: a question of life or death

  2006cited by this paper
• Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)

  2006cited by this paper
• Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition

  2005cited by this paper
• MUC1, MUC2, MUC4, and MUC5AC Expression in Salivary Gland Mucoepidermoid Carcinoma: Diagnostic and Prognostic Implications

  2005cited by this paper
• Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

  2005cited by this paper
• Pancreatic Cancer Registry in Japan: 20 Years of Experience

  2004cited by this paper
• Generation and Characterization of Anti-MUC4 Monoclonal Antibodies Reactive with Normal and Cancer Cells in Humans

  2004cited by this paper
• N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma

  2004cited by this paper
• Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma

  2004cited by this paper
• Mucins in cancer: protection and control of the cell surface

  2004cited by this paper
• PI 3-kinase, Akt and cell survival.

  2004cited by this paper
• Aberrant Expression of MUC3 and MUC4 Membrane-Associated Mucins and Sialyl Lex Antigen in Pancreatic Intraepithelial Neoplasia

  2003cited by this paper
• Cell surface association of matrix metalloproteinase-9 (gelatinase B)

  2003cited by this paper
• E-cadherin expression in primary carcinomas of the breast and its distant metastases

  2003cited by this paper
• A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.

  2002cited by this paper
• The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.

  2002cited by this paper
• MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling

  2001cited by this paper
• E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity

  2001cited by this paper
• Muc4/Sialomucin Complex in the Mammary Gland and Breast Cancer

  2001cited by this paper
• Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

  2001cited by this paper
• N-Cadherin-Mediated Cell Contact Regulates Ovarian Surface Epithelial Cell Survival

  2000cited by this paper
• The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.

  1999cited by this paper
• Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.

  1998cited by this paper
• Morphogenetic roles of classic cadherins.

  1995cited by this paper
• Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Is the guinea pig a full negative model to study the carotid body mediated Chronic Intermittent Hypoxia effects

  1983cited by this paper

• An update on the diagnostic and prognostic value of MUC4 expression in gastric cancers

  2026cites this paper
• High penetrance rare variants underlying familial lung cancer risk: Insights from genetic epidemiology of lung cancer consortium.

  2025cites this paper
• Protein interaction networks characterizing the A549 cells Klotho transfected are associated with activated pro-apoptotic Bim and suppressed Wnt/β-catenin signaling pathway

  2024cites this paper
• A new insight on alleviating the inhibitory effect of aflatoxin B1 on muscle development in grass carp (Ctenopharyngodon idella): The effect of 4-Methylesculetin in vivo and in vitro

  2024cites this paper
• Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review

  2024cites this paper
• Surface plasmon resonance microscopy identifies glycan heterogeneity in pancreatic cancer cells that influences mucin-4 binding interactions

  2024cites this paper
• Oncogenic KRAS, Mucin 4, and Activin A‐Mediated Fibroblast Activation Cooperate for PanIN Initiation

  2023cites this paper
• Pathological implications of mucin signaling in metastasis.

  2023cites this paper
• Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review

  2022cites this paper
• Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer

  2022cites this paper
• MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.

  2021cites this paper
• The role of membrane mucin MUC4 in breast cancer metastasis.

  2021cites this paper
• MUC4 Silencing Inhibits TGF-β1-Induced Epithelial-Mesenchymal Transition via the ERK1/2 Pathway in Human Airway Epithelial NCI-H292 Cells

  2021cites this paper
• Mucins: Structure and Function

  2021cites this paper
• MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression

  2021cites this paper
• Targeting cancer metastasis with antibody therapeutics.

  2021cites this paper
• Unraveling mucin domains in cancer and metastasis: when protectors become predators

  2020cites this paper
• Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4

  2020cites this paper
• MUC glycoproteins: Potential biomarkers and molecular targets for cancer therapy.

  2020cites this paper
• Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model

  2020cites this paper
• MUC4 is overexpressed in idiopathic pulmonary fibrosis and collaborates with transforming growth factor β inducing fibrotic responses

  2020cites this paper
• Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions

  2020cites this paper
• Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β.

  2020cites this paper
• Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

  2020cites this paper
• Silencing of RAD51AP1 suppresses epithelial–mesenchymal transition and metastasis in non‐small cell lung cancer

  2019cites this paper
• Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers

  2019cites this paper
• PRDM16 functions as a suppressor of lung adenocarcinoma metastasis

  2019cites this paper
• Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells

  2019cites this paper
• Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA

  2019cites this paper
• Mucins as a New Frontier in Pulmonary Fibrosis

  2019cites this paper
• MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential

  2019cites this paper
• Overview of mucin (MUC13) in gastrointestinal cancers

  2019cites this paper
• Biology, pathophysiology, and epidemiology of pancreatic cancer

  2019cites this paper
• Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.

  2018cites this paper
• Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration

  2018cites this paper
• N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer

  2018cites this paper
• Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.

  2018cites this paper
• Membrane Mucin Muc4 Promotes Blood Cell Association with Tumor Cells and Mediates Efficient Metastasis in a Mouse Model of Breast Cancer

  2017cites this paper
• The role of the signaling pathway FGF/FGFR in pancreatic cancer

  2017cites this paper
• Chapter 2 Stem Cells in Pancreatic Cancer

  2017cites this paper
• NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling

  2017cites this paper
• A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer

  2017cites this paper
• Aberrant Glycosylation In Pancreatic Cancer Progression

  2017cites this paper
• MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.

  2017cites this paper
• MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma

  2017cites this paper
• MicroRNA in pancreatic cancer

  2016cites this paper
• The canonical Wnt pathway regulates the metastasis‐promoting mucin MUC4 in pancreatic ductal adenocarcinoma

  2016cites this paper
• Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas

  2016cites this paper
• Mucins in neoplasms of pancreas, ampulla of Vater and biliary system

  2016cites this paper
• Overview of mucin (MUC13) in gastrointestinal cancers.

  2016cites this paper
• Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival

  2016cites this paper
• MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism

  2016cites this paper
• Roles of FGFR in oral carcinogenesis

  2016cites this paper
• The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer

  2016cites this paper
• Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.

  2016cites this paper
• Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus.

  2016cites this paper
• [Role of fibroblast growth factors in pancreatic cancer].

  2016cites this paper
• Regulation of the transmembrane mucin MUC4 by Wnt/β-catenin in gastrointestinal cancers

  2015influential citation
• Genetically engineered mucin mouse models for inflammation and cancer

  2015cites this paper
• MUC4-promoted neural invasion is mediated by the axon guidance factor netrin-1 in PDAC

  2015cites this paper
• Role of microRNA-150 in solid tumors (Review)

  2015cites this paper
• Role of microRNA-150 in solid tumors.

  2015cites this paper
• Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

  2015cites this paper
• Fibroblast growth factor receptors: multifactorial-contributors to tumor initiation and progression.

  2015cites this paper
• Nuclear receptors and pathogenesis of pancreatic cancer.

  2014cites this paper
• MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4.

  2014cites this paper
• Pancreatic cancer counterattack: MUC4 mediates Fas-independent apoptosis of antigen-specific cytotoxic T lymphocyte.

  2014cites this paper
• Pancreatic Cancer - Early Detection, Prognostic Factors, and Treatment

  2014cites this paper
• High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

  2014cites this paper
• Prognostic significance of mucin expression in urothelial bladder cancer.

  2014cites this paper
• Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer

  2014influential citation
• miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer

  2014cites this paper
• MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway

  2014cites this paper
• MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.

  2014cites this paper
• Stem Cells in Pancreatic Cancer

  2014cites this paper
• MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.

  2014cites this paper
• MiR-1505 p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC 4

  2014cites this paper
• Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases

  2013cites this paper
• Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

  2013cites this paper
• Emerging role of mucins in epithelial to mesenchymal transition.

  2013cites this paper
• The Role of the Tumor Microenvironment in Invasion and Metastasis of Pancreatic Cancer

  2013cites this paper
• Mucins and Cancer

  2013cites this paper
• Signaling from membrane mucins

  2013cites this paper
• The Role of EMT in Pancreatic Cancer Progression.

  2012cites this paper